Glenmark Pharmaceuticals informs about media release

23 Dec 2025 Evaluate

Glenmark Pharmaceuticals has informed that, Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the launch of Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial. Glenmark’s Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial is bioequivalent and therapeutically equivalent to the reference listed drug, Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) of BPI Labs, LLC, NDA 205029. The company has attached media release.

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

1982.00 38.65 (1.99%)
22-Jan-2026 14:45 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1628.80
Dr. Reddys Lab 1217.85
Cipla 1370.00
Zydus Lifesciences 884.55
Lupin 2161.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×